Homologous Recombination Deficiency (HRD) in Ovarian Cancer
If your pathology report or treatment records mention homologous recombination deficiency, or HRD, this refers to the result of a test that measures whether the cells in your tumour can repair a particular type of DNA damage. In ovarian cancer, HRD testing has become an important part of treatment planning because tumours that cannot perform …
Read More »
